Search for: "Genentech, Inc. v. Novo Nordisk A/S" Results 1 - 20 of 23
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Mar 2015, 9:40 am by Dennis Crouch
Novo Nordisk A/S, 132 S.Ct. 1670 (2012) (forcing correction of Orange Book listings) KSR has actually rocketed to the position of most-cited Supreme Court patent case of all time followed by Markman (1996); U.S. [read post]
14 Aug 2012, 11:14 pm
Novo Nordisk, A/S, 108 F.3d 1361, 1365 (Fed. [read post]
3 Mar 2011, 5:52 pm
Novo Nordisk A/S, 108 F.3d 1361, 1368 (Fed. [read post]
24 Nov 2010, 12:37 am by Kelly
General Global pharmaceutical linkage regulations: A consortium framework (IP Osgoode) Pfizer rolling out generics to grab off-patent market (GenericsWeb) Australia: Too little too late: CSL Limited v Novo Nordisk Pharmaceuticals Pty Ltd (No 2) and the judicial discretion to amend a patent (IP Whiteboard) Brazil: You lost your chance! [read post]
2 Nov 2010, 1:40 am
§ 314.92(a)(1); Novo Nordisk A/S v. [read post]
27 Apr 2010, 2:01 pm
Novo Nordisk A/S, 108 F.3d 1361, 1365 (Fed. [read post]
14 Oct 2009, 7:00 am
Here is IP Think Tank’s weekly selection of top Pharma & Biotech intellectual property news breaking in the blogosphere and internet. [read post]
27 Sep 2009, 2:30 pm
Novo Nordisk A/S, 108 F.3d 1361, 1366 (Fed. [read post]